Itoigawa Yukinari, Harada Norihiro, Harada Sonoko, Katsura Yoko, Makino Fumihiko, Ito Jun, Nurwidya Fariz, Kato Motoyasu, Takahashi Fumiyuki, Atsuta Ryo, Takahashi Kazuhisa
Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan.
Research Institute for Diseases of Old Ages, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
Respir Res. 2015 Apr 8;16(1):48. doi: 10.1186/s12931-015-0207-5.
Chronic airway inflammatory disorders, such as asthma, are characterized by airway inflammation and remodeling. Chronic inflammation and damage to the airway epithelium cause airway remodeling, which is associated with improper epithelial repair, and is characterized by elevated expression of transforming growth factor-β (TGF-β). Epithelial-mesenchymal transition (EMT) is an important mechanism during embryonic development and tissue remodeling whereby epithelial cells gain the capacity to increase motility by down-regulation of epithelial markers and up-regulation of mesenchymal markers. TGF-β is a central inducer of EMT, and TGF-β-induced EMT is enhanced by pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-1β. We investigated whether the pro-inflammatory cytokine TWEAK (TNF-like weak inducer of apoptosis) enhanced TGF-β1-induced EMT in the human bronchial epithelial cell line BEAS-2B.
Quantitative RT-PCR and western blotting were used to define alterations in epithelial and mesenchymal marker expression in BEAS-2B cells. The cells were assessed for 48 h after stimulation with TGF-β1 alone or in combination with TWEAK.
TGF-β1 induced spindle-like morphology and loss of cell contact, and reduced the expression of epithelial marker E-cadherin and increased the expression of mesenchymal markers N-cadherin and vimentin. Our data, for the first time, show that TWEAK reduced the expression of E-cadherin, and that co-treatment with TGF-β1 and TWEAK enhanced the TGF-β1-induced features of EMT. Moreover, hyaluronan synthase 2 expression was up-regulated by a combination with TGF-β1 and TWEAK, but not TNF-α. We also demonstrated that the Smad, p38 MAPK, and NF-κB signaling pathways, and the transcriptional repressor ZEB2 might mediate N-cadherin up-regulation by TGF-β1 in combination with TWEAK.
These findings suggest that the pro-inflammatory cytokine TWEAK and TGF-β1 have synergistic effects in EMT and may contribute to chronic airway changes and remodeling.
慢性气道炎症性疾病,如哮喘,其特征为气道炎症和重塑。慢性炎症以及气道上皮损伤会导致气道重塑,这与上皮修复不当相关,其特征为转化生长因子-β(TGF-β)表达升高。上皮-间质转化(EMT)是胚胎发育和组织重塑过程中的一种重要机制,在此过程中上皮细胞通过下调上皮标志物和上调间质标志物而获得增加迁移能力。TGF-β是EMT的核心诱导因子,促炎细胞因子,包括肿瘤坏死因子-α(TNF-α)和白细胞介素-1β可增强TGF-β诱导的EMT。我们研究了促炎细胞因子肿瘤坏死因子样凋亡微弱诱导剂(TWEAK)是否会增强TGF-β1在人支气管上皮细胞系BEAS-2B中诱导的EMT。
采用定量逆转录聚合酶链反应(qRT-PCR)和蛋白质印迹法来确定BEAS-2B细胞中上皮和间质标志物表达的变化。在用TGF-β1单独或与TWEAK联合刺激后,对细胞进行48小时的评估。
TGF-β1诱导出纺锤样形态并导致细胞间接触丧失,降低了上皮标志物E-钙黏蛋白的表达,并增加了间质标志物N-钙黏蛋白和波形蛋白的表达。我们的数据首次表明,TWEAK降低了E-钙黏蛋白的表达,并且TGF-β1与TWEAK联合处理增强了TGF-β1诱导的EMT特征。此外,透明质酸合酶2的表达通过TGF-β1与TWEAK联合处理而上调,但TNF-α则无此作用。我们还证明,Smad、p38丝裂原活化蛋白激酶(MAPK)和核因子κB(NF-κB)信号通路以及转录抑制因子锌指E盒结合蛋白2(ZEB2)可能介导TGF-β1与TWEAK联合处理导致的N-钙黏蛋白上调。
这些发现表明,促炎细胞因子TWEAK和TGF-β1在EMT中具有协同作用,可能导致慢性气道改变和重塑。